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PEMBANGUNAN METODOLOGI PENJENISAN DNA MITOKONDRIA 
UNTUK IDENTIFIKASI MANUSIA 
 
ABSTRAK 
Pengesanan mutasi dalam DNA mitokondria (mtDNA) amat berguna dalam 
laporan perubatan, analisa genetik molekular, variasi haplogroup, carian forensik dan 
pelbagai aplikasi lain.  Dalam projek ini, Single Nucleotide Polymorphisms (SNPs) 
dalam kawasan pengekodan dan kawalan pada mtDNA telah dipilih untuk 
membangunkan kit DNA. Objektif utama penghasilan kit ini adalah untuk 
menyediakan kit yang ringkas, kos efektif serta tahan lasak bagi tujuan identifikasi 
manusia. Tiga puluh SNPs yang spesifik kepada haplogroup Asia Tenggara seperti M, 
B, F, E dan N telah dipilih. Polymerase Chain Reaction (PCR) pusingan pertama 
dijalankan dengan menggunakan 25 primer yang telah direkabentuk. Produk 
amplifikasi daripada PCR pusingan pertama yang telah ditulenkan digunakan dalam 
PCR pusingan kedua atau PCR alel spesifik (asPCR) dan juga penjujukan DNA. 
Dalam asPCR, 2 jenis primer alel spesifik (ASP) telah direkabentuk iaitu wild type 
ASP (wtASP) dan variant type ASP (vtASP) untuk identifikasi variasi yang terdapat 
dalam fragmen sasaran. Dua puluh ASP telah direkabentuk dan berjaya 
mengamplifikasi SNPs sasaran. Kawalan positif dalaman PCR (IPC) telah 
direkabentuk bertujuan untuk kawalan kualiti dan mengelakkan keputusan negatif 
palsu atau positif palsu. Kajian validasi telah dijalankan dengan menggunakan sampel 
manusia (Melayu, Cina dan India), mamalia, serangga dan beberapa jenis bakteria. 
Kajian sensitiviti dijalankan dengan menggunakan sampel DNA daripada tulang purba 
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dan sampel DNA manusia yang telah dicairkan secara bersiri. Tiada produk 
amplifikasi diperoleh apabila ASP digunakan bersama template DNA daripada spesis 
lain dan ini menunjukkan ia adalah spesifik kepada DNA manusia sahaja. Hasil 
daripada ujian sensitiviti yang telah dijalankan, sebanyak 1ng/µl templat DNA 
genomik diperlukan bagi amplifikasi optimum PCR pusingan pertama. Berdasarkan 
keupayaan primer yang direka bentuk untuk amplifikasi kedua-dua pusingan PCR dan 
keputusan kajian validasi, kit penjenisan yang ringkas serta efektif untuk identifikasi 
manusia telah berjaya dihasilkan dalam kajian ini. Kit ini amat berguna untuk 
mengecilkan skop pengkelasan individu terutama dalam kes-kes seperti bencana alam, 
jenayah forensik serta nahas kapal terbang.
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DEVELOPMENT OF MITOCHONDRIAL DNA TYPING METHOD FOR 
HUMAN IDENTIFICATION  
 
ABSTRACT 
Detection of mutations in human mtDNA is useful for the purpose of medical 
reports, molecular genetic analysis, haplogroup variations, forensic search and many 
other applications. In this project, Single Nucleotide Polymorphims (SNPs) from 
coding and control regions of mtDNA were selected for development of mtDNA 
typing kit. The main objective of this kit is to provide a simple, cost effective yet robust 
identification of human remains. A total of 30 SNPs that are specific for Southeast 
Asian haplogroups such as M, B, F, E and N were selected. The first round Polymerase 
Chain Reaction (PCR) was performed using 25 sets of in house designed primers. The 
purified amplified products were used in second round PCR known as allele specific 
PCR (asPCR) and also sent for sequencing to confirm the sequence of the amplified 
products. In asPCR, two types of allele specific primers (ASPs) for wild type ASP 
(wtASP) and variant type ASP (vtASP) were designed to identify the polymorphisms 
within the target fragments. A total of 20 ASPs were successfully designed and able 
to amplify the targeted SNPs. For quality control purpose and also to avoid false 
positive or false negative results in asPCR, an internal positive PCR control (IPC) was 
developed and incorporated together in the same tube during asPCR. A validation 
study for this mtDNA typing kit was carried out using human DNA samples (Malay, 
Chinese and Indian), mammals, insects and several types of bacteria. Sensitivity study 
was carried out using DNA extracted from ancient bones and serial dilution of fresh 
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human DNA sample. The ASPs are only specific for human DNA as no amplification 
was observed when using DNA template from other species. Based on the sensitivity 
validation study, the minimum amount of genomic DNA template required for 
optimum amplification of first round PCR is 1ng/µl. Based on the successful 
amplifications of both round PCRs using in house designed primers and the validation 
studies results, a simple yet effective mtDNA typing kit for human identification has 
been successfully developed in this study. This kit would be very much useful to 
narrow down individual classification especially in cases of mass disaster, forensic 
crime and plane crash. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Mitochondrial DNA and Single Nucleotide Polymorphisms  
Determination of DNA variations contributes to classification and sometimes 
up to unique identification in human. The Short Tandem Repeats (STRs) and Single 
Nucleotide Polymorphisms (SNPs) are well known in the studies of human genetic 
variations. Presently STRs are preferable and provide large contribution in many 
forensic cases because of their variations at a unique physical location. STRs are 
a microsatellites, consist of a unit of two to thirteen nucleotides repeated hundreds of 
times in a row on the DNA strand while SNPs are a variations of a 
single nucleotide that occur at specific positions throughout the genome. Generally, 
the SNP which in majority are biallelic markers, are the most abundant forms of DNA 
polymorphisms observed in human genome and estimated to occur at 1 in every 1,000 
bases in human genome (Glover et al., 2010).  
Although the discrimination power of each SNP is lower to that of STR but the 
combination and collaboration of the mutation could realize a high discriminating 
power (Inagaki et al., 2004). The SNPs are in great interest currently as they could be 
used as markers to identify genes that predispose individuals to complex disorders by 
using linkage disequilibrium. The SNPs can also be applied in forensic genetics and 
therefore SNPs typing has been focused in this field (Asari et al., 2009). The SNPs 
have several characteristics that are suitable for several studies especially forensics. 
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SNPs can be analyzed from short amplicons and this is desirable as almost all forensic 
samples are degraded (Köhnemann et al., 2008). Its low mutation is very precious for 
paternity testing and it is also suitable for analysis using high-throughput technologies, 
which have become important for the successful implementation of large population 
DNA databases and make it easier to perform large population studies (Sobrino et al., 
2005).  
Mitochondrial DNA (mtDNA) becomes interest of this study compared to 
nuclear DNA as there are 1,000-10,000 copies of mtDNA per cell. Because of this 
valuable characteristic, it is useful especially in cases of inadequate samples (Hoong 
& Lek, 2005). In the early years of forensic DNA typing, studies on human DNA are 
based on restriction fragment length polymorphisms (RFLP) that refers to the 
differences among samples using different locations of restriction enzymes sites in 
either genomic DNA or mtDNA. In addition, the circular shape of mtDNA provides 
stability to survive in extreme conditions which is useful in forensic investigation 
especially that involves archeological samples. Although mtDNA has little 
information compared to nuclear DNA as it is solely inherited from mother, the criteria 
still make it precious in matrilineal study. 
In this study, the focus is on mitochondrial DNA SNPs (mtSNPs) due to their 
abundance throughout the entire mitochondrial genome. It has been shown that 
mtDNA replacement mutations lead to regional varieties in the mtDNA coding region 
(Liao & Lee, 2010). In addition, mtDNA coding regions’ SNPs are involved in a broad 
spectrum of diseases. Polymorphisms of mtDNA genome have been reported to be 
useful for identity testing and analysis of degraded material or samples containing little 
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or no genomic DNA (Boonyarit et al., 2014). Using polymorphisms that are observed 
in mtDNA genome in relation to the reference sequence, individuals are categorized 
into monophyletic clades or haplogroups that represent related groups of sequences 
defined by shared mutation (Anderson et al.,1981) 
Populations in the same haplogroup normally share their ancestor due to 
existence of similar haplotypes in the haplogroups. The combination of these alleles at 
different mtDNA regions caused them to closely link and tend to be inherited together. 
Due to this fact, it is usually possible to predict haplogroup from these kinds of 
haplotypes. The collaboration of mtSNPs able to produce specific identification for 
each population. Thus, selection of these SNPs may indicate population of individual 
hence giving group determination of individual even at early stage of investigation.  
Selections of mtDNA SNPs for this study are based on haplogroups reported 
specifically for Southeast Asian populations. Simple haplogroup discrimination will 
not lead to sufficient results as majority of Asian populations belong to 
superhaplogroup M and N (Ricaut et al., 2009). Thus a subtyping of superhaplogroup 
M and N with further discriminating SNPs is inevitably necessary. The unspecific 
SNPs like hot-spot SNPs that mutate in different haplogroup background are not 
preferred as they cannot discriminate haplogroup specifically (Köhnemann et al., 
2008). Haplogroup E is reported specifically belong to Southeast Asian populations 
especially Island Southeast Asia and therefore several SNPs in haplogroup E were 
selected to be incorporated in this mitochondrial DNA typing kit. Other SNPs in 
subhaplogroups such as M9, M9a, M9a’b, N21, R21, and F1a1a were also added to 
further enhance the discrimination power of this typing kit.  
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1.2 Problem statement 
Screening of mtDNA SNPs is important nowadays since specific SNPs indicate 
specific haplogroups. In cases of mass disaster, identification of missing/detached 
limb/organs using autosomal STRs method can be very expensive. For this kind of 
cases, this kit may help in grouping the detached limbs or small bones and provides 
preliminary result in the proses of human genotyping. In addition, autosomal STRs 
cannot be used to narrow down the identification based on population especially when 
dealing with mass disaster victims and the technique also requires longer time for 
identification. (Alonso et al., 2005; Glover et al., 2010). On the other hand, mtDNA 
offers greater possibility of getting DNA profile from degraded or very limited DNA 
samples, which is not possible when using autosomal STRs (Boonyarit et al., 2014). 
The mtDNA typing kit developed in this study will offer a better option for human 
identification, which is lower in cost, not depending upon expensive high technology 
instruments, easy yet robust. 
Nowadays there are several tools, kits and also techniques that can be used to 
detect human DNA for human identification. Most of these techniques used STRs as 
markers for individual identification. In 2004, Japan was hit by massive tsunami 
(Dawson et al., 2004) that have caused thousands of people died. As it attacked coastal 
area, not only local people were dead but tourists were also among the casualties 
(Løvholt et al., 2014). Corpse identification was a difficult process as many of the 
bodies were totally smashed during the catastrophic incident. Using normal 
procedures, classification of those victims was a long and tedious process as search 
and rescue team has to send DNA samples to laboratories for identification purpose 
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(Alonso et al., 2005). Identification is rather straight forward if family members are 
able to identify the body or willing to provide their DNA samples as reference. 
Problem will arise when no family member comes forward to identify the body.  
Another example that required massive procedure for victim’s identification was 
MH17 crash in Ukraine in 2014. The ill-fated aircraft with a total of 298 passengers 
on board was shot down, killing all 283 passengers and 15 crews on board 
(Samarasekera, 2014). As the plane fell down from 10,000 feet above sea level, the 
bodies of the victims were severely mutilated. The investigation team reported that 
they found part of human bodies scattered around within the marked 10 km square feet 
crime scene. The remains were collected and DNA analysis was carried out for 
identification purpose. In the beginning, grouping of the intact bodies or limbs or 
organs according to their population couldn’t be performed. Overall, normal procedure 
of DNA typing in such case is sampling (collection of the intact bodies or fragments), 
obtain DNA samples from both victims and family members for reference purpose and 
the last process is DNA analysis by comparing the sample’s DNA profile and reference 
profile. Not all the body parts collected from the crime scene were in good condition. 
Referring to this case, dealing with internal politic issues has delayed the collection 
process. The research and rescue teams were only allowed to access the crime scene 
after several days and therefore when dealing with degraded and small quantity of 
DNA, mtDNA is considered as the best solution. Based on these two cases discussed, 
the mtDNA typing kit developed in this study may offer a better option in narrowing 
down the detection process as it can be used to classify the bodies at the very first stage 
using a much faster and simple technique that can be brought to the crime scene. 
Furthermore, the cost is much lower as compared to other methods. Current DNA 
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typing techniques mostly cost around one thousand ringgit per sample, which may 
include the initial primer design up to sequencing process for human identification   
1.3 Research objectives  
The main objective of this project is to develop mitochondrial DNA typing 
method for the identification of Southeast Asian populations in forensics investigation. 
The specific objectives of this project are: 
i) To design and optimize primers for amplification of selected SNPs within 
the mitochondrial DNA control and coding regions. 
ii) To design and optimize allele specific primers (ASP) against the amplified 
fragments.  
iii) To design and optimize synthetic oligonucleotide as an internal PCR 
control in allele specific PCR (asPCR). 
iv) To perform specificity validation of the developed kit across different 
animal species that includes mammals (primates and cat), insects, and 
bacteria. 
v) To determine the sensitivity of the developed kit using degraded DNA 
samples (DNA extracted from ancient bones) and diluted DNA samples 
vi) To validate the developed kit on Malaysian populations (Malay, Chinese 
and Indian). 
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1.4 Scope and limitation 
Selection of SNPs sites that are specific for Southeast Asian populations is not 
quite straight forward as these polymorphisms may also represent Asian populations 
in general. Furthermore, some of the selected SNPs are shared by different 
haplogroups, which decrease the discrimination process. Increasing the number of 
SNPs in a way may help to minimize this limitation. Among all of the selected 
haplogroups, haplogroup E is specifically belongs to Island Southeast Asian and 
therefore combination of these polymorphisms with other SNPs may discriminate and 
classify the Southeast Asian populations better. On the hand, the amplified fragments 
are quite small for the purpose of forensic application. Due to this, the sequencing 
process may not be able to amplify the required SNPs because of noises production 
during sequencing for instance due to SNP that is closely located at the primer binding 
site. 
1.5 Importance of study 
The main objective of this research is to develop a robust, simple and cost 
effective mtDNA typing kit for application in forensic cases. Currently the available 
methods involve laborious techniques and high end instruments, which are not suitable 
when dealing with huge number of biological samples and most of the analysis cannot 
be carried out at the crime scene. The most popular DNA typing technique proposed 
and used nowadays is real time PCR, also known as quantitative PCR (qCPR). This 
technique could be specific and non-specific fluorescent dyes that intercalate with the 
DNA sequences. Although it is reported as an accurate typing technique, a specific 
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software is required to perform the analysis. Prior to qPCR, it involves similar DNA 
extraction method as any other DNA typing technique hence all the steps are 
conducted in laboratory and not practical to be carried out in the crime scene. 
In order to shorter the analysis period, several new DNA typing techniques 
have been proposed that can be brought to the investigation field yet the robustness is 
maintained. The desire to take DNA testing capabilities out of laboratory to a crime 
scene has leaded the development of portable DNA testing devices. In certain cases, 
the developed rapid DNA device might aid elimination of innocent suspects early in 
an investigation. According to (Butler, 2012), much of work so far has been focused 
on miniaturizing the DNA separation steps and the focus is on STR typing. 
A microchip based laboratory, or so called ‘labs on a chip’ is an application of 
microfabrication method into miniature to miniaturize the sample preparation and 
analysis steps in forensic DNA typing. It permits investigation of biological evidence 
at the crime scene or more rapid and less expensive DNA analysis in a conventional 
laboratory setting (Paegel et al., 2003). The miniature of capillary electrophoresis (CE) 
in this technique is shorter channels or known as capillaries which will lead to faster 
DNA separations. According to the report by (P. Liu et al., 2008), this CE device has 
been used to perform investigation onsite in a mobile van and the results managed to 
be produced within in less than six hours. 
Robustness are measured by the reproducibility of the results and capability of 
this typing kit to be conducted on site. The optimized PCR programs and the designed 
primers that are specific to human DNA, must be able to produce consistent results 
9 
 
regardless being used in different laboratories and by different operators. With the 
availability of the portable PCR machine in the market such as Ahram Biosystems, 
AAS Inc, Biomeme and Biometra that are mostly battery operated, DNA identification 
process is able to be carried out on site. This will significantly reduce the turnaround 
time for analysis and the hassle of transporting the samples to laboratories. 
However, all of the techniques previously proposed used STR instead of SNPs. 
Hence, the development of this mtDNA typing kit is important as it can be applied in 
both individual and population studies. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Introduction 
  The use of mitochondrial DNA instead of nuclear DNA in Forensic DNA 
analysis is due to several reasons such as quantity and conditions of the sample itself. 
Samples may be found from low-copy number materials such as shed hair or highly 
degraded bones due to severe exposure towards environmental conditions. The best 
way to deal with the problems is by using mtDNA that presents in high copy number 
within cells (Kline et al., 2005). The main purpose of this project is to develop a kit 
for identification of human remains using mtDNA single nucleotide polymorphisms 
(mtSNPs) specifically for Southeast Asian (SEA) populations. The selected mtDNA 
SNPs were the ones classified as the defining SNPs for the particular haplogroups 
predominantly found in SEA.  
2.2 Mitochondrial DNA typing kit  
The development of mtDNA SNPs typing kit is not new but the approaches, 
combination of methods in this kit and the target populations are different. In this kit, 
a total of 30 mtDNA SNPs within the control and coding regions were selected to be 
included in this kit. The methods include two rounds of PCR that amplify the templates 
in the first round PCR and identification of SNPs using allele specific PCR (asPCR). 
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A group of researchers in National Institute of Standards and Technology 
Gaithersburg had developed a typing kit using control and coding regions in mtDNA 
for screening purpose but they covered only eleven loci and specifically designed for 
Caucasian group. This typing kit was designed to detect mutations using probes 
attached to the allele specific primer extension (Kline et al., 2005).  
Another typing kit using mtDNA SNP for screening purpose was developed 
with 16 targeted SNPs in hypervariable regions for European population but the 
approach was totally different. This research used mini sequencing method that relies 
upon a single base extension of a primer immediately adjacent to the SNP using 
fluorescently labelled ddNTPs prior to sequencing (Brandstätter et al., 2004). In 2008, 
the European DNA Profiling (EDNAP) Group developed the mtDNA typing kit that 
focused on 16 nucleotide positions in coding region. This typing kit has allowed the 
discrimination of major West Eurasian mtDNA haplogroups by using multiplex PCR 
and Snapshot miniseqencing (Parson et al., 2008).  
A mitochondrial DNA Typing kit that has been developed by Salas et al. (2005) 
was almost similar to the developed kit in this study. The kit was designed to 
discriminate the nucleotide polymorphisms in haplogroup H, a common European 
haplogroup for 40-50% of the European populations. In this particular kit, the typing 
technique allowed to allocate common West Eurasian mtDNA haplotypes into their 
corresponding branches of mtDNA skeleton. The target mtDNA locations include 
HV1, HV2 and also coding region. The methods approached in this typing kit were 
multiplex PCR and also SNaPshot reaction with ddNTPs labeled with dye. From all 
mtDNA typing kits developed before, the trend of using real time PCR was preferred 
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and the analysis was based on the fluorescent color that has been used to label ddNTPs 
or primers. The asPCR method especially has not been used in mtDNA typing kits 
developed before. 
2.3 Disaster victim identification (DVI) 
 Mass disasters in the form of natural or man-made, can involve loss of life for 
many victims of the tragedy. Efforts to identify these victims are referred to as disaster 
victim identification (DVI). Nowadays, DNA test has become routine and expected in 
DVI in the event of plane crash, large fire or terrorist attack. Normally, mass disasters 
will leave human remains in pieces or beyond recognition. Sometimes, body parts can 
be separated from one another and the remains degraded making identification without 
DNA techniques is quite impossible. The use of fingerprints and dental records still 
plays an important role in victim identification but the approaches require a finger or 
an intact skull or jawbone along with archived fingerprint and dental records that can 
be made available for comparison purposes. 
 DNA test has a major advantage that it can be used to identify each and every 
portion of the remains recovered from site provided two conditions that there is 
sufficient intact DNA present to obtain a DNA type and reference sample is available 
for comparison purpose. The comparison involves post-mortem (PM) and ante-
mortem (AM) data. PM data are generated from the recovered human remains, which 
may be highly fragmented depending on the type of disaster. AM data come from 
either direct reference samples or kinship comparisons to biological relatives. 
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 So far, DNA testing has been used to help in identifying victims of numerous 
airline crashes, the victims of terrorist attacks, recovered remains from mass graves 
and in natural disasters such as SEA tsunami that occurred in December 2004 and 
Huricane Katrina that struck New Orleans in August 2005. On 11 September 2001, the 
terrorist attacks against the World Trade Center (WTC) and Pentagon in Washington 
DC. More than 19917 pieces of human remains were collected from the tragedy. 
According to the report, the initial removal and sorting of human remains took place 
between September 2001 and May 2002. However, the primary DNA identification 
only went for more than 3 years. One of the largest challenges from this investigation 
was the process of reviewing the massive amounts of data produced by laboratories 
(Macqueen, 2009). 
 Other than that, DNA testing is also applied in individual identification from 
mass graves. One of the major challenges for performing DNA identification from 
mass grave is dealing with degraded samples. In this case, mtDNA often is the only 
source of successful DNA recovery from bones that have been in the ground for many 
years (Huffine et al., 2001). Again, dealing mass DNA samples will consume longer 
time and increase the cost. Based on this two cases, the developed kit is strongly 
relevant to be applied in this type of cases especially that involved massive number of 
victims. DNA identification is directly performed on site with less time consuming yet 
cost effective (Butler, 2012). 
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2.4 Selection of haplogroups 
Knowledge on mtDNA haplotypes becomes crucial and important in 
application of mtDNA markers especially in forensic studies. The mtDNA haplotypes 
strongly correlate to geographic origin (Maruyama et al.,, 2010). Even it is seldom 
preferred in individual unique identification, screening of several mtDNA regions 
might narrow down the scope of investigation in cases that involved unclassified 
populations. 
A total of 30 mtDNA SNPs from both coding and control regions have been 
chosen in this study. All the selected mtDNA SNPs  represented major haplogroups of 
SEA based on previous reports (Kong et al., 2006; Macaulay et al., 2005; M. S. Peng 
et al., 2010). In this study, the selected mtDNA SNPs from coding regions were SNP 
13,626, 3552, 1709, 1719, 9080, 3394, 13362, 4491, 3027, 3705, 9512, 7684, 1872 
and 8440 while the mtDNA SNPs within the control region were SNP at nucleotide 
position 16390, 16261, 16266, 16355, 16335, 16291, 16093, 16108, 16274, 153, 146, 
16148, 16309, 16287, 195 and 479. The major haplogroups involved were macrogroup 
M and N together with their branches and subclades of E, R, B, and F (Kong et al., 
2006).  
The nucleotide positions in mitochondrial genome were numbered from 1 to 
16569 according to the revised Cambridge Reference Sequence (rCRS) (Bandelt et al., 
2014). All single nucleotide polymorphisms (SNPs) including insertions or deletions 
(indels) were scored as differences (mutations) to rCRS. As the previous research were 
mainly focused on the HV1, HV2 and HV3 regions of mtDNA, this study will focus 
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on both mtDNA regions. Although most of the previous studies have focused on 
control regions, there was a study that investigated the complete control region and 
some specific coding region polymorphisms. This research team has conducted the 
study to obtain more reliable indicators of mtDNA haplogroups and compare with 
other datasets on SEA, East Asian and neighboring populations (Maruyama et al., 
2010).  
The non-coding region (also known as control region) is effectively shorter 
than the coding region with 1.1 kb that covers bases from 16024 to 576 (Figure 2.1). 
The mutation rate that for these two regions is not equal across the entire mtDNA. It 
was reported that the overall mutation rate highly occured in the control region as 
compared to coding region. The control region is a non-coding region that is important 
for mtDNA replication thus accumulates more mutations. Several types of local 
differences in the mutation rate among all these nucleotide positions can be observed 
such as hot spot SNPs or known as SNPs that are prone to mutation and site-specific 
(hyper) mutability. Among these nucleotide positions, several sites act as mutational 
hot spots in the control region such as positions 146, 150, 152, 195, 16189, 
16311,16362 and 16519 whereas others appear rather stable such as position 477, 493, 
16108 and 16129.  
Previous reports recorded that non coding region consists of higher overall 
mutation rate but the mechanism that boosted up this event remains to be elucidated. 
Due to higher mutation rate, the sequence variation can be easily observed in control 
region and preferred by the researchers for various applications. But still, the 
determination of some haplogroups cannot be depended on control regions only even 
16 
 
though there were haplogroups assigned solely based on control region data such as 
J1b1 and K19a. However,  it’s more reliable if the data from control regions and coding 
region are combined together (Oven & Kayser, 2008). 
As in control region, the coding region also contains of nucleotide positions 
that are prone to mutate which will lead to homoplasy or also known as recurrence in 
phylogeny. The reported nucleotide positions include 709, 1719, 3010, 5460, 10398, 
11914, 13105, 13708 and 15884.  
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Figure 2.1: Map of human mitochondrial DNA (Montoya et al., 2006) 
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Regarding haplogroups classification, a group of researchers has suggested that 
climate was the most important factor that influence human mtDNA evolution (Ruiz-
Pesini et al., 2004) but the issue has been challenged by other investigators stated that 
climate was not the only factor that determine human mtDNA evolution. Other than 
climate, population immigration and genetic mutation were claimed as factors that 
contributed to human mtDNA evolution (Sun et al., 2006). Asian populations were 
mainly belonging to M, N and R macrohaplogroups. Originally, the M and R 
macrohaplogroups derived from macrohaplogroup L which was reported as root of 
human mtDNA phylogenetic trees. As such, macrohaplogroup L represented the most 
ancestral mitochondrial lineage of all currently living modern humans and it was 
reported as African origin of modern humans. The major subclades listed in 
macrohaplogroup L were L0, L1, L2, L3, L4, L5, L6 and L7. The non-Africans were 
all reported exclusively descended from haplogroup L3 that expanded to 
superhaplogroup M and N. The C, E, G, Q and Z were the haplogroups under M 
macrohaplogroup. The expansion from N macrohaplogroup were A, I, O, R, S, W, X 
and Y. The R macrogroups later expands to B, F, J, P, T, HV, H, V and K haplogroups 
(van Oven & Kayser, 2009). Figure 2.2 previews map of world human mtDNA 
migrations and each continent specific haplogroups. 
The L3 group radiated out of Africa in the form of macrohaplogroup M and N 
around 60kya (thousand years ago) and reported to enter South Asia and India sub-
continent and later drifted to SEA and Australia (Figure 2.2). But actually there was 
an issue and controversy surrounding the origin of this haplogroup. Some of previous 
researchers believed that M haplogroup was originated in Asia and represented a 
backflow to Africa while other researchers believed from their researches that M 
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haplogroup was truly originated from Africa and then migrated to Asia (Winters, 
2010). The report of M haplogroup was originated from Africa has been supported by 
several recent studies which strengthen the statement  (Maji et al., 2009; Malhi et al., 
2007; M. S. Peng et al., 2010; Ricaut et al., 2009; Winters, 2010). Other reports 
suggested that East Asian mtDNA pool was locally region-specific and mostly covered 
by superhaplogroup M and N (Kivisild et al., 2002). 
Amongst all branches of macrohaplogroup M, group M9 is well distributed in 
Asian origins. Most basal branches of M9a except M9a1 was reported following the 
distribution in Southern China and SEA. This pattern suggested that M9a might have 
a southern origin (M.-S. Peng et al., 2011). Apart from haplogroup M9, group M7 also 
has been found in East and SEA (S. D. Lee et al., 1997). According to (Maruyama et 
al., 2010), the M12, M21b and M22  lineage has been found in SEA populations with 
high percentage in Aboriginal Malay  that brought the suggestion of having those 
haplogroups as Malay markers. Haplogroup E that was rooted out from haplogroup 
M9 was reported as exclusively belong to Island SEA. The branches of haplogroup E 
were determined using control and coding region mutations as discrimination between 
groups in haplogroup E was not possible in some cases using control regions alone 
(Soares et al., 2008).
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          Figure 2.2: Map of world human mtDNA migrations and continent specific haplogroups (http://.mitomap.org/MITOMAP)
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Beside M, macrohaplogroup N was another group that rooted out from L3 and 
radiated to haplogroup R and diverged rapidly within haplogroup N about 60kya 
(Macaulay et al., 2005). From this N macrohaplogroup, N21 and N22 have been found 
in Southeast Asia and more common in the aboriginal populations in Malay Peninsula 
(Hill et al., 2007; Maruyama et al., 2010). The haplogroup R branches out further into 
haplogroup B and haplogroup F with several subclades each. The B and F were 
reported as major haplogroups and have been found in Continental East Asia and also 
Island SEA (Maruyama et al., 2010). In previous study, it was mentioned that one of 
the most common haplogroups in ISEA was haplogroup B, which fell into two main 
clades, B4 and B5 (Hill et al., 2007). In this group, haplogroups B1c1b and B4c1b3 
were found more frequently in Island SEA although almost all B lineage were SEA 
common haplogroups and widely distributed in SEA populations (Maruyama et al., 
2010).  
Other major haplogroups in R was haplogroup F that branched out from R9. 
Among all kinds of F subhaplogroups, F1a has been found frequently in all East Asia, 
SEA and ISEA with F1a1a relatively restricted to mainland SEA and Island SEA 
(Kivisild et al., 2002). The F1a2 and F1a3 groups seems to be rare lineage in East Asia 
and SEA and some recurrence mutations have been found in F subclades for example 
SNP 16355 that was shared by F3a and M9a (Hill et al., 2007). Figure 2.3 shows the 
summary of human mtDNA lineage. 
Various populations have been found in different locations for both Mainland 
SEA and Island SEA. Above all, the findings of SEA populations were mainly based 
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Figure 2.3: Simplified human mtDNA lineages (van Oven & Kayser, 2009)
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on the languages used by those populations and of course geographic was the main 
factor that influenced the languages and their lifestyles. The language used by SEA 
populations recorded for both Mainland SEA and Island SEA have gave us general 
information on the migrations of SEA populations. From previous studies that mainly 
focused on the languages used, several SEA populations were recorded and grouped 
based on their geographical locations. The recorded languages managed to provide 
general information on populations found in SEA although it was believed that the 
reported data still did not cover the whole populations that belong to SEA. 
2.5 SNPs of the selected haplogroups 
Overall, the selection of mtDNA SNPs in this study were strictly based on SEA 
haplogroups classification. The SNP variants occurred in many ways such as deletion, 
insertion, transition and also transversion. From the updated mtDNA haplogroup tree 
that was accessed from MITOMAP (www.mitomap.org), all recorded mutations were 
transitions type except indicated other than that. Transition can be explained as 
nucleotide changes in the same group for example purine to purine and pyrimidine to 
pyrimidine while transversion can be described as nucleotide changes from purine to 
pyrimidine or vice versa. The purine group consists of nucleotide A and G while 
nucleotide T and C is grouped in pyrimidine (Greco & Tor, 2005). The nucleotide 
variants in each of selected SNPs are listed in Table 2.1. Several SNPs are also shared 
by other macrohaplogroups. 
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In previous reports, several SNPs shared similar variants with other 
haplogroups, even across their macrohaplogroups. Out of the 30 selected SNPs, only 
6 of them were recorded as exclusively belong to specific haplogroup. The SNPs were 
the ones at nucleotide positon 13626 (haplogroup E), 3552 (haplogroup N21), 9080 
(haplogroup E2), 13362 (haplogroup M9), 3027 (haplogroup E) and 7684 (haplogroup 
R9c) and 1872 (R21). Recurrent mutations have been found for several SNPs and they 
were shared by multiple haplogroups for instance polymorphisms at nucleotide 
position 16390, 16261, 16291, 16093, 146 and 195. The defining SNPs for each 
haplogroup are listed in Table 2.2.
